Target intelligence / Profile preview

Plasmodium vivax heme detoxification pathway (None established)

Target
None established
Molecular classification
Other (Biochemical pathway), Enzyme (e.g., Heme Detoxification Protein, falcipain family), Protein complex (multiple associated proteins involved)
01

Overview

The Plasmodium vivax heme detoxification pathway is a critical metabolic process in malaria parasites, responsible for neutralizing the toxic heme released during hemoglobin digestion inside infected red blood cells. As the parasite digests host hemoglobin, large amounts of free heme are liberated; this molecule is highly toxic due to its capacity to generate free radicals and peroxidative cellular damage. To avoid heme-mediated toxicity, Plasmodium species convert free heme into an insoluble crystalline material called hemozoin. This transformation occurs mainly in the parasite's digestive vacuole and involves several proteins, notably Heme Detoxification Protein (HDP) and falcipain-family proteases[1][5][7]. The heme detoxification pathway is a central and validated antimalarial drug target, with several major drug classes (e.g., chloroquine, artemisinin, and related compounds) exerting their antimalarial activity by inhibiting hemozoin formation, complexing with heme, or disrupting heme processing[2][4][6][8]. Disruption of this pathway leads to toxic heme accumulation, oxidative stress, and parasite death. The molecular details of hemozoin formation and the full complement of involved proteins remain areas of active research, particularly as drug-resistant malaria strains emerge. While most current drugs are directed at the P. falciparum pathway, the same fundamental process is essential in P. vivax, making this pathway universally relevant in malaria treatment strategies. The pathway itself is not a single molecule and should not be mapped as a “receptor” but as a complex/critical metabolic pathway containing several protein moleculer targets, principally the HDP and associated digestive enzymes.[1][5][7]

Other names
Heme detoxification pathwayHemozoin formation pathwayHeme crystallization pathwayHDP-mediated pathway
02

Mechanism of action

Inhibition of hemozoin (malarial pigment) crystal formation - Complexation with free heme to prevent crystallization - Alkylation or binding to heme, causing toxic buildup of reactive oxygen species and cellular oxidative damage - Disruption of hemoglobin digestion-heme detoxification coupling

03

Biological functions

Heme detoxificationHemoglobin digestion byproduct managementProtection from oxidative toxicity (conversion of toxic heme to inert hemozoin)
04

Disease associations

Infection (essential for malaria parasite survival during blood stage)
05

Safety considerations

Development of drug resistance (e.g., to chloroquine, artemisinin)Potential off-target toxicity with some agents (notably non-selective ROS-inducing compounds)Need for selective targeting to minimize toxicity to host erythrocytes
06

Interacting drugs

Chloroquine

6 more in the full profile.

07

Biomarkers

Hemozoin levels (measurable malarial pigment)Accumulation of free heme (experimental marker)Not routinely used clinically

Beyond the preview

Go deeper on Plasmodium vivax heme detoxification pathway (None established).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium vivax heme detoxification pathway (None established).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call